| Reaction Details |
|---|
 | Report a problem with these data |
| Target | 5-hydroxytryptamine receptor 4 |
|---|
| Ligand | BDBM325598 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Cell-Based Assay |
|---|
| EC50 | 66.0±n/a nM |
|---|
| Citation |  Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V Heteroaryl compounds as 5-HT4 receptor ligands US Patent US9636335 Publication Date 5/2/2017 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| 5-hydroxytryptamine receptor 4 |
|---|
| Name: | 5-hydroxytryptamine receptor 4 |
|---|
| Synonyms: | 5-HT-4 | 5-HT4 | 5-HT4S | 5-HT4a | 5-HT4b | 5-HT4c | 5-HT4d | 5-HT4hb | 5-hydroxytryptamine receptor 4 | 5-hydroxytryptamine receptor 4 (5-HT4) | 5HT4R_HUMAN | HTR4 | Serotonin (5-HT) receptor | Serotonin (5-HT3) receptor | Serotonin 4 (5-HT4) receptor | Serotonin Receptor 4 |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 43767.54 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q13639 |
|---|
| Residue: | 388 |
|---|
| Sequence: | MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIV
SLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYY
AICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSN
STYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRP
QSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL
GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRD
AVECGGQWESQCHPPATSPLVAAQPSDT
|
|
|
|---|
| BDBM325598 |
|---|
| n/a |
|---|
| Name | BDBM325598 |
|---|
| Synonyms: | 3-[5-(1-Cyclopropylmethyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-1-isopropyl-1H-indazole | US9636335, 39 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C21H27N5O |
|---|
| Mol. Mass. | 365.472 |
|---|
| SMILES | CC(C)n1nc(-c2nnc(o2)C2CCN(CC3CC3)CC2)c2ccccc12 |
|---|
| Structure | 
|
|---|
Search and Browse
